Flow Neuroscience Secures FDA Approval for At-Home Depression Treatment
Flow’s groundbreaking at-home brain stimulation device for treating depression has already been adopted by clinics across the UK, Europe, and beyond, supporting more than 55,000 users. The technology is now set to launch in the United States in Q2 next year. Flow Neuroscience has announced FDA approval of its breakthrough at-home brain-stimulation device for the…
